array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "Gsk Consumer Health, Inc." ["slug"]=> string(32) "4abba-us-gsk-consumer-health-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204" ["description"]=> string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company." ["address_street"]=> string(28) "184 Liberty Corner Rd Ste 78" ["address_place"]=> string(6) "Warren" ["address_region"]=> string(10) "New Jersey" ["founding_date"]=> string(10) "1994-02-28" ["website_domain"]=> string(7) "gsk.com" ["website_url"]=> string(19) "https://www.gsk.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(300) ["article_count"]=> int(385) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(53) "GSK reveals data on novel gonorrhoea drug gepotidacin" ["snippet_en"]=> string(131) "GSK reveals data from EAGLE-1 trial of novel antibiotic gepotidacin for gonorrhoea, amid growing resistance to existing antibiotics" ["url"]=> string(80) "https://pharmaphorum.com/news/gsk-reveals-data-novel-gonorrhoea-drug-gepotidacin" ["image_url"]=> NULL ["source"]=> string(16) "pharmaphorum.com" ["publication_date"]=> string(10) "2024-04-17" ["categories"]=> array(1) { [0]=> string(13) "Data Security" } } [1]=> array(7) { ["title_en"]=> string(105) "Canada sanctions individuals and entities affiliated with Sudan warring parties - Dabanga Radio TV Online" ["snippet_en"]=> string(123) "Yesterday, Canadian Foreign Affairs Minister Mélanie Joly announced sanctions against two individuals and four entities..." ["url"]=> string(128) "https://www.dabangasudan.org/en/all-news/article/canada-sanctions-individuals-and-entities-affiliated-with-sudan-warring-parties" ["image_url"]=> string(78) "https://images.businessradar.com/articles/fecca742-44f2-47fd-a7f1-49782a9b26dc" ["source"]=> string(16) "dabangasudan.org" ["publication_date"]=> string(10) "2024-04-16" ["categories"]=> array(3) { [0]=> string(11) "Geopolitics" [1]=> string(9) "Sanctions" [2]=> string(18) "General Investment" } } [2]=> array(7) { ["title_en"]=> string(84) "The shingles virus "attacks" five monuments in Spain due to a GSK awareness campaign" ["snippet_en"]=> string(89) "The pharmaceutical company GSK has carried out an awareness campaign about shingles to..." ["url"]=> string(139) "https://www.infosalus.com/farmacia/noticia-virus-herpes-zoster-ataca-cinco-monumentos-espana-campana-concienciacion-gsk-20240415184329.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/373de802-2484-48e4-b74b-12775094e194" ["source"]=> string(13) "infosalus.com" ["publication_date"]=> string(10) "2024-04-15" ["categories"]=> array(1) { [0]=> string(21) "Cultural developments" } } [3]=> array(7) { ["title_en"]=> string(62) "Aranda withstands the industrial pulse and the firms transform" ["snippet_en"]=> string(177) "Unlike Miranda, which has a loss of 45 companies, the unions point out that in the river capital "more than losing, many firms transform." The construction does notice a decline" ["url"]=> string(144) "https://www.diariodeburgos.es/noticia/z3e20aed9-c796-dc26-c6e29db1f55bd517/202404/aranda-aguanta-el-pulso-industrial-y-las-firmas-se-transforman" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4e8f4291-37e5-4b4b-9a75-c9512e08f22b" ["source"]=> string(17) "diariodeburgos.es" ["publication_date"]=> string(10) "2024-04-14" ["categories"]=> array(2) { [0]=> string(19) "Investment Requests" [1]=> string(18) "General Investment" } } [4]=> array(7) { ["title_en"]=> string(46) "The Siena City Council on Friday 12 April 2024" ["snippet_en"]=> string(121) "The work of the Siena City Council meeting on Friday 12 April 2024 in the continuously updated Captain of the People room" ["url"]=> string(84) "https://sienafree.it/157163-il-consiglio-comunale-di-siena-di-venerdi-12-aprile-2024" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ac843a1f-66b9-44c2-95f6-1f9e26de0a5d" ["source"]=> string(12) "sienafree.it" ["publication_date"]=> string(10) "2024-04-12" ["categories"]=> array(0) { } } [5]=> array(7) { ["title_en"]=> string(65) "AgriTechE partners with One Nucleus to discover more about plants" ["snippet_en"]=> string(66) "Collaboration will look into properties for potential drug trials." ["url"]=> string(117) "https://www.cambridgeindependent.co.uk/business/agriteche-partners-with-one-nucleus-to-discover-more-about-p-9361157/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/482aa890-f546-45b1-99e6-8e94190e43e3" ["source"]=> string(26) "cambridgeindependent.co.uk" ["publication_date"]=> string(10) "2024-04-11" ["categories"]=> array(2) { [0]=> string(13) "Collaboration" [1]=> string(8) "Epidemic" } } [6]=> array(7) { ["title_en"]=> string(30) "The organization was a miracle" ["snippet_en"]=> string(426) "For years they were employed as contract workers alongside their friends, but did not enjoy the same rights. When their company, Ness Technologies, violated their few rights, they decided to join the Histadrut and demand to be taken in for direct employment. Micah Weinberger (40), the leader of the organization: "I will never forget the day we were informed that we were being hired directly as company employees at Partner." ["url"]=> string(32) "https://www.davar1.co.il/503215/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/7fa9823c-42ea-4722-a6fc-507cdf02a6ec" ["source"]=> string(12) "davar1.co.il" ["publication_date"]=> string(10) "2024-04-11" ["categories"]=> array(2) { [0]=> string(5) "Legal" [1]=> string(15) "Labor Practices" } } [7]=> array(7) { ["title_en"]=> string(109) "The reason why Kwangdong Pharmaceutical is strengthening its ‘prescription medicine’ business - Nate View" ["snippet_en"]=> string(829) "Kwangdong Pharmaceutical is strengthening its prescription drug portfolio. It is interpreted as a strategy to improve the profit structure that is biased towards the F&B (food and beverage business) sector and to raise the corporate value, which is lower than that of competing pharmaceutical companies with sales of 1 trillion won. Vaccine sales normalize... expectations for new items ↑ According to Bizwatch's analysis of Kwangdong Pharmaceutical's business report on the 10th, sales of prescription drugs last year were KRW 135.8 billion, up 34.3% from the previous year. Although the proportion of prescription drugs in total sales is only 14.8%, it increased by 2.9 percentage points over the same period, showing the only increase among all business sectors. The reason for the increase in sales of prescription drugs is" ["url"]=> string(39) "https://view.nate.com/tech/view/160443/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2596b9d3-cc4b-4f0d-b865-d40d2722c245" ["source"]=> string(8) "nate.com" ["publication_date"]=> string(10) "2024-04-09" ["categories"]=> array(0) { } } [8]=> array(7) { ["title_en"]=> string(70) "Corporate bosses are forced to get creative to talk up price increases" ["snippet_en"]=> string(111) "‘Price pack architecture’ is latest jargon to describe price increases without unleashing public opprobrium" ["url"]=> string(63) "https://www.ft.com/content/e76fc704-370c-4921-8d23-c6f2c4e865d6" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ed5d1658-eca3-48b2-b292-768040293fcd" ["source"]=> string(6) "ft.com" ["publication_date"]=> string(10) "2024-04-08" ["categories"]=> array(1) { [0]=> string(18) "General Investment" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(24) } [1]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(23) } [2]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(20) } [3]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(19) } [4]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(18) } [5]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(14) } [6]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(14) } [7]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(13) } [8]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(13) } [9]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(13) } [10]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(11) } [11]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(10) } [12]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(10) } [13]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(9) } [14]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(9) } [16]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(7) } [18]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(7) } [19]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(6) } [20]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(6) } [21]=> array(2) { ["name"]=> string(24) "Employee Health & Safety" ["count"]=> int(6) } [22]=> array(2) { ["name"]=> string(6) "Crisis" ["count"]=> int(6) } [23]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(23) "Supply Chain Management" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(5) } } } 4abba-us-gsk-consumer-health-inc